Skip to main content
Fig. 8 | Journal of Nanobiotechnology

Fig. 8

From: Advances in the modulation of ROS and transdermal administration for anti-psoriatic nanotherapies

Fig. 8

Lipid nanomaterials-based transdermal drug delivery platform for the treatment of psoriasis. a The preparation of the DLNP transcutaneous delivery system could improve the skin penetration of STAT3-inhibiting peptides for efficiently treating psoriatic skin inflammation without causing adverse systemic events. Reproduced with permission [153]. Copyright 2018, American Chemical Society. b Hybrid polymer-lipid nanoparticles in combinational with photosensitizer TPPS2a for delivery of siRNA were aimed to topical treat psoriasis effectively through optimizing the endosomal escape of TNFα siRNA in the cytoplasm. Reproduced with permission [208]. Copyright 2021, Elsevier. c Lipid-hybridized CNF film was successfully prepared for transdermal delivery of curcumin to cure psoriasis. Reproduced with permission [206]. Copyright 2018, Elsevier

Back to article page